Cancer medicines
Imatinib
Imatinib
An oral targeted therapy for selected leukemias and gastrointestinal stromal tumors.
Sources checked · Introductory guide
On this page
How it works
It inhibits specific kinase signals involved in cancer cell growth.[2]
Where it is used
Used in settings including Philadelphia-positive CML and KIT-positive gastrointestinal stromal tumors.[1]
Key safety points
Monitoring and interaction checks are needed. Report sudden swelling, weight gain or breathlessness immediately.[2]
Questions for your care team
- Which tests confirm the target and monitor response?
Sources and scope
Source documents are in English.
Entries summarize and translate linked official public sources. The source-check date records when those sources were checked; it does not indicate a clinician’s review.
General information based on official public sources. This is not a complete list of uses or side effects. Individual treatment decisions require your care team and current source documents. US-source uses do not establish local approval or reimbursement.
Related entries
NGS testing
TestsComplete blood count (CBC)
TestsLiver function tests
Cancer medicinesSunitinib
Cancer typesChronic myeloid leukemia
Cancer typesAcute lymphoblastic leukemia
Cancer medicinesDasatinib
Genes & biomarkersBCR::ABL1 fusion
Genes & biomarkersKIT variants
Genes & biomarkersPDGFRA variants